hagocytosis has a critical role in neutralization and termination of pathogens 1 , but it also contributes to a diverse range of developmental, homeostatic and noninfectious disease processes, including apoptotic cell clearance, senescent erythrocyte turnover, tumor surveillance, elimination of cellular debris after injury, and synaptic pruning [2] [3] [4] [5] [6] [7] [8] . Imbalances in phagocytosis by macrophages or other 'non-professional' phagocytes 9,10 can lead to autoimmunity, developmental deficits and buildup of toxic protein aggregates 2, 4 . Phagocytes use distinct surface receptors and signaling cascades to engulf different types of particles 11 , and elucidating additional molecules that make differential contributions across substrates will help enable narrowly targeted therapeutics for correcting phagocytosis defects in specific diseases.
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Depending on the features of the substrate targeted for engulfment, phagocytes use a spectrum of signaling cascades to achieve rapid cytoskeletal reorganization and substrate ingestion [11] [12] [13] [14] . Much of our understanding about the molecular basis of phagocytosis derives from forward genetic screens in model organisms. Classical apoptotic cell engulfment screens in Caenorhabditis elegans have identified (among other genes) phagocytic receptors ced-1 and ced-6 as well as key signaling intermediates, ced-5 and ced-10, which activate the SCAR/WAVE complex during apoptotic cell clearance 15, 16 . Ced gene human orthologs DOCK1, CRK, ELMO1 and RAC1 perform analogous signaling functions in mammalian SCAR/WAVE recruitment to activated phagocytic receptors 17, 18 . Additional organismal forward-genetic screens conducted in fruit flies and zebrafish have both corroborated prior findings and provided new insights into regulation of phagocytosis [19] [20] [21] [22] . RNA interference screens in cultured Drosophila melanogaster S2 cells have also identified numerous phagocytic regulators [23] [24] [25] [26] , although a systematic screen for regulators of phagocytosis in mammalian cells has not been reported.
The development of the CRISPR/Cas9 system [27] [28] [29] has enabled markedly improved genome-scale knockout screens with high precision in mammalian cells [30] [31] [32] [33] [34] [35] [36] [37] . With an appropriate selection strategy, pooled CRISPR screens allow for effective and systematic interrogation of complex cellular processes. Although such screens have been used successfully in a number of cases, comparative analysis of genome-scale screens has been limited by the cost and effort required either to grow large panels of cells extensively or to perform FACS-based sorting, which can be expensive and time consuming.
Here, we describe a strategy for rapid selection of large-scale human cell populations using phagocytic ability as a direct readout. This strategy relies on magnetic separation of cells that have engulfed paramagnetic particles. We conducted eight distinct genome-wide CRISPR screens to investigate mechanisms of phagocytosis for distinct particle types in the macrophage-differentiated human myeloid cell line U937. Taken together, this work defines multiple pathways central to human cell phagocytosis, and demonstrates a generalizable strategy using magnetic separation to rapidly identify regulators of phagocytosis for diverse substrates. Results A magnetic separation screen for phagocytosis regulators. To systematically investigate the requirements for phagocytosis of a wide range of substrates, we sought to leverage the power and efficiency of pooled CRISPR screening. We selected a human myeloid cell line with phagocytic activity, U937 cells 38 , and optimized a differentiation protocol ( Supplementary Fig. 1a-c ) that allowed the cells to robustly phagocytose diverse types of particles in a manner that depended on actin dynamics and that could be inhibited by cytochalasin D (Supplementary Fig. 1d,e) . We then generated a knockout pool of U937 cells by stably expressing Cas9 and introducing a ~200,000-element lentiviral library of single-guide RNAs (sgRNAs) targeting every protein-coding gene in the genome with ten distinct sgRNAs per gene and ~10,000 negative-control sgRNAs 32 .
Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens
To directly probe the dynamic cellular process of phagocytosis, we developed a magnet-based selection strategy in which U937 cells were rapidly separated based on their capacity to phagocytose superparamagnetic substrates. After incubation with superparamagnetic particles, cells were passed through a uniform magnetic field that captured magnetized cells that ingested paramagnetic particles while nonmagnetized cells that did not phagocytose passed through (Fig. 1a) . Magnet-bound cell fractions were highly enriched for phagocytosing cells, with a single superparamagnetic bead conferring sufficient magnetism to capture associated cells on the column (Fig. 1b) . Pretreatment of cells with cytochalasin D prevented magnetic capture, suggesting that surface-associated but noningested particles were efficiently removed ( Supplementary Fig. 1f ).
Identification of known and novel phagocytosis regulators.
Having established a phenotypic selection assay, we next performed a genome-wide screen for regulators of phagocytosis in duplicate. In our initial screen we exposed a pool (2.5 × 10 8 cells) of differentiated, Cas9-expressing U937 cells containing a genome-wide knockout library to 1.3 μ m-diameter superparamagnetic beads for a duration (30 min) optimized to allow for subsequent capture of ~80% of the cells on the magnet. Each sorted fraction was preserved and processed separately, allowing direct comparison of sgRNA abundance in magnet-bound versus unbound cellular fractions within each replicate. Importantly, magnetic selection of the large number of cells required for screening was routinely completed in 1-2 h, at least an order of magnitude faster than fluorescence or survival-based selections at this scale.
After cell separation, sgRNA sequences were recovered from genomic DNA and sequenced to determine the relative enrichment of each sgRNA in bound versus unbound fractions. Gene-level effects were derived using casTLE 39 , with top negative and positive regulators showing clear enrichment across multiple sgRNAs relative to the distribution of both nontargeting and safe-targeting negative-control sgRNAs (Fig. 1c) . Analysis of replicate screen data for 1.3 μ m-diameter carboxy-coated beads identified 85 genes at 10% false discovery rate (FDR), including genes that promote and inhibit particle uptake (Fig. 1d, Supplementary Fig. 1g and Supplementary Tables 1 and 2 ). Genes enriched in the unbound fraction (denoted by a negative effect score) lead to decreased particle uptake when disrupted, and therefore are normally necessary for efficient phagocytosis. Conversely, genes enriched in the bound fraction (denoted by a positive effect score) lead to increased particle uptake when disrupted, and therefore normally inhibit phagocytosis. Pathway analysis for the 85 genes discovered as hits in the 1.3 μ m bead screen showed strong enrichment of Reactome pathway terms related to phagocytosis and actin polymerization ( Fig. 1e and Supplementary Table 1) . Indeed, identified genes encompassed a nearly complete actin polymerization cascade known to be essential for phagocytic cup formation, including RAC1, DOCK2, five members of the five-subunit SCAR/WAVE complex (NCKAP1L, WASF2, ABI1, CYFIP1 and BRK1) and five members of the seven-subunit ARP2/3 complex (ACTR2, ACTR3, ARPC2, ARPC3 and ARPC4; Supplementary Fig. 1g ).
Beyond canonical phagocytosis machinery, the hits were enriched for biological pathway categories related to positive regulation of mTOR signaling (Fig. 1e, Supplementary Fig. 1g and Supplementary Table 1 ). The mTOR-associated Ragulator complex and its regulatory target, RagA, have recently been identified as strong modifiers of microglial phagocytic flux in a zebrafish screen 22 , a finding supported by identification of RagA (RRAGA) and three of five members of the Ragulator complex (LAMTOR2, LAMTOR3 and LAMTOR4) by our screen in human cells (Fig. 1e and Supplementary Fig. 1g ). Additionally, our initial screen identified NPRL2 of the RagAinhibiting GATOR1 complex as a gene that promotes phagocytosis when disrupted (Supplementary Fig. 1g ). In addition to known factors, unexpected hits involved in lipid metabolism and sialic acid biosynthesis and the poorly characterized genes NHLRC2, TM2D1, TM2D2 and TM2D3 represent some of the strongest genetic regulators of phagocytosis in this system, with either general or selective effects on particle uptake (Supplementary Fig. 1g ).
Diverse screens find general and substrate-specific hits. To allow for magnetic selection of cells based on phagocytosis of additional substrates, we covalently conjugated 30 nm-diameter iron oxide nanoparticles (IONPs) to purified myelin, zymosan (yeast cell wall particles) and sheep red blood cells (RBCs) conjugated with either IgG (IgGRBC) or complement (CompRBC). We also sought to more directly address the function of particle size and charge in phagocytosis. To this end, we performed additional genome-wide screens using superparamagnetic beads of 0.43 μ m diameter (SmallBeads), 4.3 μ m diameter (BigBeads), as well as oppositely charged, cationic 1.3 μ m-diameter beads (PosBeads) (Fig. 1a) . Magnetic labeling and phagocytosis of each substrate were optimized for efficient separation of phagocytosing U937 cells (Fig. 1f, Supplementary Fig. 2a -j, Supplementary Table 3 and Supplementary Note). We conducted genome-wide phagocytosis screens for all eight substrates, each in duplicate. Screen hits were typically moderately to highly expressed by both differentiated U937 cells and primary human microglia (Supplementary Fig. 3a and Supplementary Table 4); this suggests that our approach identifies genes relevant for phagocytosis in U937 cells and primary macrophages.
To compare the highest-confidence phagocytosis regulators across all eight screens, we compiled a list of 150 genes containing genes recovered at FDR ≤ 5% in at least two independent substrate screens. Unbiased hierarchical clustering highlighted distinct categories of genes whose deletion either promoted or inhibited phagocytosis for all substrate types, or whose deletion had differential effects for different types of substrates. In general, genes known to participate in the same process clustered together (Fig. 1g) .
We manually binned genes recovered at FDR ≤ 5% in at least three genome-wide screens into functional categories based on their reported roles within the cell (Fig. 2) . Among the highest-confidence hits were the aforementioned members of the SCAR/WAVE and ARP2/3 complexes, all ten nonredundant members of which were hits for almost every substrate screened. The ARP2/3 complex has recently been shown to be of limited importance for IgG-mediated phagocytosis 40 , and ARP2/3 components showed the lowest signal in IgGRBC screens (Fig. 2) . Among the most prominent negative regulators of phagocytosis were seven genes associated with sialic acid biosynthesis and protein sialylation (Fig. 2) . Genes related to surface signaling (such as the integrin-associated genes ITGB2, TLN1 and FERMT3) and intracellular phosphorylation cascades (such as PP2A, MAPK and PKC-related genes) were among the hits with the strongest differential impact across different substrates.
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To further refine a high-confidence set of differential hits across diverse substrates, we again used our magnetic separation approach to screen the small sublibrary using six substrates at much higher coverage than in the genome-wide screens (60,000 cells per unique guide versus 1,000 cells per unique guide). This increased coverage, as determined by the number of cells per unique guide, improves the sensitivity and robustness of large-scale screens 33, 41 . In particular, for certain substrates the genome-wide screens exhibited low signal and high noise ( Supplementary Fig.  3b ), possibly due to the single magnetic separation step or heterogeneous differentiation and phagocytosis in U937 cells. Although the FDR can be controlled with stringent filtering, this may lead to many false negatives, that is, genes that affect phagocytosis but do not reach significance due to noise and/or small effect sizes. As we expected, the high-coverage sublibrary screens showed higher reproducibility between replicate screens ( Supplementary Fig. 3c ) and general agreement with genome-wide screens ( Supplementary  Fig. 4a,b) , although certain screens showed some apparent false positive results. The batch retest screens showed phenotypes for many genes that had been missed in the genome-wide screens (false negatives). Additionally, we created a library targeting the 218 mouse genes whose human orthologs showed strong effects in the genome-wide midbead screen and screened it using FACSbased separation in one of the most widely studied phagocytic cell lines, mouse RAW 264.7 cells. Although this cross-species comparison in a different cell line identified many genes that seem to have species-specific or cell-type specific effects on phagocytosis, 81 of the genes in this library still demonstrated a significant phagocytosis phenotype (Supplementary Fig. 4b and Supplementary Table 5 ). Together, these focused, high-coverage sublibrary screens largely confirmed hits identified in genome-wide screens, and further supported the findings of strong effects for several poorly characterized genes (Supplementary Table 5 ).
Additionally, we generated 34 stable U937 cell lines expressing Cas9 and individual sgRNAs targeting hits identified at 10% FDR in our genome-wide screens, and confirmed high rates of gene editing ( Supplementary Fig. 4g ). We then measured rates of phagocytosis using automated time-lapse microscopy of pHrodo-labeled substrate. For example, differentiated U937 cells expressing sgRNAs against the SCAR/WAVE complex member NCKAP1L exhibited markedly reduced phagocytosis (Fig. 3c,d ). These orthogonal timelapse microscopy validation assays demonstrated varying degrees of reduced or increased phagocytic capacity across multiple substrates, largely mirroring the original screen results ( Table 7) and validated contributions of genes with no previously reported role in phagocytosis (Fig. 3e) . Together, about 70-80% of genes (depending on substrate) measured in these individual assays exhibited a phenotype consistent with their phenotype in the pooled screens. Finally, we validated the roles of select genes by CRISPR editing in primary human macrophages isolated from peripheral blood, suggesting that hits discovered in these screens are not limited to immortalized cell lines (Figs. 3f,5e and 6f and Supplementary Fig. 4i ).
Identifying substrate-selective phagocytosis regulators. Notably, the screens identified several genes whose disruption had a differential impact on phagocytosis for certain substrates. To directly test the effect of these genes on substrate preference, we adapted our live-imaging phagocytosis assay to simultaneously monitor uptake of two separate particles labeled with pHrodo red and pHrodo green, respectively (Fig. 3g) . Using this approach, we challenged several sgRNA-expressing U937 cell lines either with a mixture of red zymosan and green positive midbeads or with a mixture of red CompRBC and green positive midbeads. Consistent with the screen results, U937 cells expressing sgRNAs against integrinrelated genes TLN1 and FERMT3 showed marked reduction in phagocytosis of zymosan and CompRBC, whereas their ability to phagocytose beads remained intact ( Fig. 3h-j) . Additionally, we confirmed that PLEK, which coordinates actin polymerization and is enriched at the phagocytic cup 42, 43 , also contributes to uptake of zymosan and complement-opsonized red blood cells, but not beads ( Fig. 3h-j) .
Multiple magnetic screens predicted that knockout of PLEK, TLN1, ICAM1 and CDK2 would boost bead phagocytosis. Notably, whereas cell lines expressing CDK2 sgRNAs similarly increased uptake of beads measured using pHrodo-labeled beads (which measure pH drop upon phagosome fusion to the lysosome) ( Supplementary Fig. 4d ), there was no increase in phagocytosis in pHrodo-based assays for ICAM1, PLEK or TLN1 knockouts ( Fig. 3h-j and Supplementary Fig. 4d ). To investigate this discrepancy, we tested cells carrying sgRNAs for PLEK or TLN1 in magnetic separation assays after exposure to magnetized zymosan or magnetic beads. Indeed, these assays again confirmed deficits in zymosan uptake for these lines and showed increased capture of bead-exposed cells ( Supplementary Fig. 4f ). U937 cells carrying ICAM1 sgRNAs similarly showed no effect in pHrodo-based assays, but showed increased magnetic capture after phagocytosis of magnetic beads or zymosan ( Supplementary Fig. 4e ). Thus, although the assays are largely well correlated (Fig. 3b) , certain phagocytosis regulators we identified showed selective effects in magnetic bead uptake versus pHrodo bead uptake assays; this could reflect action at distinct steps of phagocytosis. This underscores the value of using orthogonal assays to probe the activity of identified phagocytosis regulators.
Discovery of an essential role for NHLRC2 in phagocytosis.
A particularly conspicuous hit from our screening data sets was NHLRC2, a poorly characterized gene that was reproducibly one of the strongest hits required for phagocytosis in almost every screen. To further validate the role of NHLRC2 during phagocytosis, we examined its function in RAW 264.7 cells. RAW 264.7 cell lines were generated that constitutively expressed Cas9 and an sgRNA targeting either NHLRC2 or the SCAR/WAVE component NCKAP1L. We observed almost identically strong defects in phagocytosis for two independent sgRNAs targeting each of these genes ( Supplementary  Fig. 5a ). To further validate this observation, we generated clonal NHLRC2 knockout RAW 264.7 and U937 cells, confirmed them by Sanger sequencing (Supplementary Fig. 4h ) and found severe phagocytosis deficits. (Fig. 4a,b and Supplementary Fig. 5b ). We also validated the inhibitory effect on phagocytosis when knocking out these genes in primary human macrophages (Fig. 3f) .
To investigate the molecular function of NHLRC2, we performed BioID pulldown experiments 44 using a mutant form of the biotin ligase enzyme BirA (BirA*) fused to NHLRC2 in order to make a BirA*-NHLRC2 fusion protein. This approach allows for the unbiased assessment of transient or stable NHLRC2 interactions within the native cellular environment of differentiated U937 cells. BirA*-NHLRC2 pulldown samples were highly enriched for several transmembrane and perimembrane proteins in addition to NHLRC2 itself ( Fig. 4c and Supplementary Table 8 ). To our surprise, none of the partners were identified as a hit in any of our phagocytosis screens, possibly due to redundancy of NHLRC2-associated proteins (see Discussion). However, gene ontology and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis of pulldown hit genes identified enrichment in annotated phagocytosis regulators (Supplementary Table 8) , with two candidates (LSP1 and p190RhoGAP) directly implicated in directing actin polymerization at the cell surface 45, 46 . Therefore, we hypothesized that NHLRC2 contributes to phagocytosis by assisting LSP1 or p190RhoGAP coordination of actin polymerization.
p190RhoGAP (also known as GRLF1 or ARHGAP35) is a negative regulator of RHOA and localizes to the phagocytic cup 47 . RHOA influences bundled actin dynamics and antagonizes Rac1-mediated rearrangements of branched cortical actin. We therefore tested whether loss of Nhlrc2 alters RHOA or RAC1 activation. Nhlrc2 knockout RAW 264.7 cells showed substantially elevated levels of RHOA activation specifically during phagocytosis, although global levels of RAC1 activation were minimally altered in total cell lysates ( Fig. 4d and Supplementary Fig. 5c ). We next tested whether enhanced Rac1 activity could overcome Nhlrc2 knockout phagocytic deficits by overexpressing a constitutively active Rac1 mutant (RAC1 p.Gln61Leu). RAC1 p.Gln61Leu overexpression rescued the phagocytic defect of Nhlrc2 knockout cells without affecting control or Nckap1l knockout cells, supporting a model in which NHLRC2 is required for cytoskeletal rearrangements downstream of particle binding and receptor engagement (Fig. 4e) . Closer examination of cellular morphology by scanning electron microscopy (SEM) revealed a marked loss of surface filopodia specific to Nhlrc2 knockout cells relative to wild-type or Nckap1l knockout cells ( Fig. 4f and Supplementary Fig. 5e ), supporting a role for NHLRC2 in regulation of actin protrusions. We observed the absence of filopodia in Nhlrc2 knockout cells using confocal microscopy after phalloidin staining to label F-actin ( Fig. 4g and Supplementary Fig. 5d ) as well as the failure of these cells to form organized actin structures in a frustrated phagocytosis assay ( Fig. 4h and Supplementary Videos 1 and 2). Together, these data suggest a model in which NHLRC2 negatively regulates RHOA, enabling RAC1-mediated cytoskeletal changes that are critical for phagocytosis (Fig. 4i) .
VLCFAs are necessary for efficient phagocytosis. Some of the unexpected screen hits were members of a sequential lipid biosynthesis pathway (Fig. 5a ). These included a fatty-acid elongase that generates very-long-chain fatty acids (VLCFAs) (ELOVL1), and a ceramide synthase that specifically incorporates VLCFAs into ceramides (CERS2); both were strong hits for multiple substrates (Fig. 1g) . A downstream sphingomyelin synthase that adds a zwitterionic head group to a diverse range of ceramides (SGMS1) 48 was also a hit, though with weaker and more variable effects. In validation experiments, sgRNAs targeting any of these three enzymes strongly reduced phagocytosis of zymosan (Fig. 5b) . To test whether the contribution of these genes to phagocytosis is solely related to the presence of these lipid species, we performed metabolic rescue experiments. Phagocytosis deficiency of cells with disrupted ELOVL1 function was rescued by supplementation with its product VLCFAs (a mixture of C24:0 and C24:1) but not with its substrate medium-chain fatty acids (a mixture of C18:0 and C18:1, Fig. 5c,d) . Importantly, control cells were not affected and cells carrying an sgRNA against the downstream enzyme CERS2 were not rescued. We further validated the role of ELOVL1 in phagocytosis by CRISPR editing in primary human macrophages; despite incomplete gene editing ( Supplementary Fig. 4i ), we observed a significant decrease in phagocytosis upon ELOVL1 gene disruption (Fig. 5e) .
Notably, confocal microscopy of ELOVL1 knockout RAW 264.7 cells incubated with IgG-coated 7 μ M beads and fixed after 10 min indicated that a majority of phagocytic cups are stalled at early cup formation. In contrast, we observed all steps of phagocytic cup formation, including fully engulfed beads, in control cells (Fig. 5f,  Supplementary Fig. 6a and Supplementary Videos 3,4) . The phenotype of early phagocytic cup stalling in ELOVL1 knockout cells was also observed with SEM ( Fig. 5g and Supplementary Fig. 6b ).
Because the process of cell migration involves similar actin dynamics and many of the same molecular components as phagocytosis, we tested whether VLCFAs might have a role in migration. Notably, knockdown of ELOVL1 in a human neutrophil cell line (PLB-985) reduced basal cell migration speed, although not as strongly as knockdown of positive-control genes (ACTR2 and RAC2, which have roles in both phagocytosis and cell motility 49 ( Supplementary Fig. 6c ). This motility defect was reduced after stimulation with a formyl peptide chemoattractant ( Supplementary  Fig. 6d ). For the two sgRNAs we tested, the strength of the knockdown was correlated with the strength of the phenotype ( Supplementary Fig. 6c-e) . Taken together, our results suggest a previously unappreciated role of these specific VLCFAs in basic immune cell functions requiring large morphological transitions such as macrophage phagocytosis and neutrophil motility.
Alzheimer's risk gene TM2D3 controls amyloid-β uptake. In addition to the integrin-related genes we identified as specifically affecting uptake of a subset of particles ( Supplementary Fig. 7a,b) , we chose to focus on the TM2D family (TM2D1, TM2D2 and TM2D3), several components of which were consistently recovered as hits required for phagocytosis for various bead types but were either not hits or had weak effects on uptake of most biological particles (Figs. 1g and 2) .
TM2D1 has been implicated in binding to amyloid-β peptide 50 , and a TM2D3 variant allele has been recently identified as strong risk factor for late-onset Alzheimer's disease, with an odds ratio of 3.5-15.9 (ref. 51) . Therefore, we hypothesized that TM2D family members participate in engulfment of amyloid-β protein aggregates. To test this proposal, we generated small pHrodo-conjugated amyloid-β aggregates according to described protocols 52 . Control cells showed actin-dependent accumulation of pHrodo signal, and uptake was abolished with the addition of cytochalasin D (Supplementary Fig.  7c ). Uptake of pHrodo-conjugated amyloid-β aggregates was also markedly reduced in U937 cells with sgRNAs targeting universally required phagocytosis regulators, such as NCKAP1L and NHLRC2 (Supplementary Fig. 7c ). Because phagocytosis of both amyloid-β aggregates and synaptic material are thought to be important for Alzheimer's disease progression 4 and our screens predicted strong substrate-specific contributions of TM2D family members, we next tested whether knockout lines could discriminate between simultaneously applied pHrodo-red amyloid-β and pHrodo-green synaptosomes. TM2D2 and TM2D3 knockout lines showed substantial deficiencies in amyloid-β phagocytosis, but less of a change in clearance of synaptic material in a competition assay (Fig. 6a-c) , highlighting the potential significance of central nervous system (CNS) substrate-specific contributions of TM2D family proteins to the balance of phagocytosis in Alzheimer's disease. To further confirm the role of TM2D family proteins, we tested the role of TM2D3 in the phagocytosis of amyloid-β aggregates and zymosan in primary human macrophages. Electroporation with Cas9 ribonucleoprotein complexes targeting TM2D3 inhibited the phagocytosis of amyloid-β aggregates by peripheral blood monocyte-derived macrophages, but no change was detected for zymosan phagocytosis (Fig. 6d) . Together, these data suggest that loss of TM2D3 function may impair clearance of amyloid-β aggregates and related particles, with more limited impact on phagocytosis of other substrates.
Discussion
Here, we developed a rapid and efficient strategy to identify genes that control diverse aspects of phagocytosis using magnetic separation. We have implicated many known and uncharacterized genes as positive or negative regulators of phagocytosis, and validated the roles of dozens of individual genes using orthogonal assays. Together, our data illuminate both universal and substrate-specific principles of phagocytosis and identify multiple novel and poorly characterized genes that are central to phagocytic processes.
NHLRC2, one of the strongest hits across almost all of our screens, has been poorly characterized but is broadly expressed at relatively low levels in many cell types 53 . During preparation of this manuscript, mutations in NHLRC2 were found to be associated with fatal fibrosis, CNS vascular abnormalities, and neurodegeneration in humans 54 , and a role was proposed for NHLRC2 in protection from cell death induced by reactive oxygen species 55 . Our results show that knockout of NHLRC2 in U937 and RAW 264.7 cells profoundly inhibits phagocytosis of several types of substrates. Rescue of murine Nhlrc2 knockout cells with constitutively active Rac1 suggests that phagocytic signaling can be restored and that cells lacking NHLRC2 protein are otherwise capable of executing the steps required for phagocytosis. With the additional observation that NHLRC2 associates with p190RhoGAP and alters activation of the cytoskeleton regulator RHOA, we propose a model in which NHLRC2 helps to initiate localized RHOA inhibition, enabling RAC1-driven cytoskeletal rearrangement during initiation of phagocytosis. The mechanism by which loss of NHLRC2 results in loss of filopodia (Fig. 4f,g ) will require further investigation, but may partially explain the profound defect in phagocytosis observed in these mutant cells 56 . We found clusters of genes with differential effects on distinct substrates; for example, integrin signaling is required for uptake of several biological particles but not charged beads (Figs. 1g and 2 ). Integrins can act as phagocytic receptors themselves, but they also facilitate initiation of phagocytic signaling cascades after engagement of other surface receptors. Additionally, we found that PLEK, which serves to localize and initiate signaling cascades that direct cytoskeletal rearrangements and can be localized to the phagocytic cup 42, 43 , has a role only upon engagement of certain substrates. Conversely, many genes regulate phagocytosis of beads but not biological particles (Fig. 1g) . Further studies will be necessary to investigate the mechanisms that account for these differences.
In considering hits with disproportionate impacts on different particle types, we were particularly intrigued by the TM2-domain family members because they are poorly characterized and have been implicated in neurodegenerative disease. We found that TM2D2-and TM2D3-deficient cells show impaired clearance of amyloid-β aggregates, and that the phagocytic defect had a disproportionate effect on protein aggregates relative to another CNSrelevant substrate. Previous findings that TM2D1 can directly bind to amyloid-β peptide 50 suggests that these genes may contribute to initial events required for aggregate uptake. However, all three TM2-domain family members are broadly expressed by diverse cell types 53 , and they may have a more general role in cellular signaling events related to disease progression.
The ability to rapidly screen for phagocytosis regulators at the genome scale makes it possible to investigate how phagocytosis machinery changes across cellular activation states or in diverse environmental conditions. Further optimization could address limitations of this approach and should allow more detailed dissection of particular steps of phagocytic particle engulfment (see Supplementary Note). Together, this work establishes a broadly applicable strategy for investigating complex cellular uptake processes and promises to yield insights into diseases characterized by dysregulated phagocytosis.
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Methods
U937 cell culture and differentiation. U937 cells were acquired from the American Type Culture Collection (CRL-1593.2). Cells were maintained in suspension culture using spinner flasks for library propagation and tissue culture plates for single-gene knockout lines, all in sterile-filtered U937 growth medium (RPMI1640 supplemented with 2 mM glutamine, 100 units ml -1 penicillin, 100 mg ml -1 streptomycin and 10% heat-inactivated FCS). Cells were cultured in a humidified 37 °C incubator set at 5% CO 2 . Cells were passaged two to three times weekly. To generate frozen aliquots, cells were pelleted by centrifugation (300g, 7 min, room temperature), suspended in 90% FCS and 10% dimethylsulfoxide (DMSO), and frozen in cell-freezing containers at − 80 °C overnight before transfer to liquid nitrogen for long-term storage.
For differentiation, U937 cells were diluted to a density of 1-2 million cells ml -1 in U937 growth medium containing phorbol myristate acetate (PMA) to achieve a final concentration of 50 nM PMA. Cells were plated on tissue culture plastic and allowed to differentiate and adhere for 3 d. After differentiation, cells were recovered by harvesting supernatants and trypsinizing adherent cells. For trypsinization, cells were washed three times with PBS (137 mM NaCl, 2.7 mM KCl, 8 mM sodium phosphate dibasic, 2 mM potassium phosphate monobasic, pH 7.4), incubated in PBS containing 300 units ml -1 trypsin for 7 min at 37 °C and then recovered from the plate by repeated pipetting of the solution to dislodge cells. Trypsinized adherent and nonadherent supernatant cells were pooled, pelleted by centrifugation (300g, 7 min, room temperature) and resuspended in fresh U937 growth medium. Cells were then plated and allowed to recover for 2 d before assays were performed. For screens, 100 million differentiated U937 cells were plated in 100 ml of U937 growth medium in 15 cm tissue culture dishes. For validation assays and other experiments, cells were plated at a density of 500,000 cells ml -1 in 96-well plates.
CD11b staining. U937 cells were differentiated in 50 nM PMA as described above, or they were left undifferentiated and 500,000 cells per well were plated in a glassbottom 24-well plate. On day five post-differentiation cells were washed twice with cold dPBS, blocked with 500 μ l 3% BSA in dPBS for 1 h and then incubated for 30 min with 500 μ l of a 1:200 dilution of the CD11b antibody (Biolegend, 101202, clone M1/70). Cells were then washed three times with cold dPBS. Secondary antibody (donkey anti-rat AlexaFluor 488, Thermo Fisher, A-21208) was added at a 1:1,000 dilution in Dulbecco's phosphate-buffered saline (dPBS) and incubated in the dark for 1 h. Cells were then washed five times in cold dPBS. Cells were then incubated with a 1:10,000 dilution of Hoechst nuclear stain for 3 min in the dark and washed once with cold dPBS.
RAW 264.7 cell culture. RAW 264.7 cells were acquired from the American Type Culture Collection (TIB-71). Cells were maintained on tissue culture plastic in RAW growth medium (DMEM supplemented with 2 mM glutamine, 100 units ml -1 penicillin, 100 mg ml -1 streptomycin and 10% heat-inactivated FCS). Cells were passaged by gently lifting the cells with a disposable cell scraper, pelleting by centrifugation (300g, 7 min, room temperature) and replating the cells in fresh RAW growth medium.
Library preparation. The 10-sgRNA-per-gene CRISPR/Cas9 deletion library was synthesized, cloned and infected into Cas9-expressing U937 cells as described 32 . Briefly ~300 million U937 cells stably expressing SFFV-Cas9-BFP were infected with the ten-guide-per-gene genome-wide sgRNA library at a multiplicity of infection < 1. Infected cells underwent puromycin selection (1 μ g ml -1 ) for 5 d, after which puromycin was removed and cells were resuspended in normal growth medium without puromycin. After selection, sgRNA infection was measured as > 90% of cells as indicated by measuring mCherry-positive cells with flow cytometry. Sufficient sgRNA library representation was confirmed by deep sequencing after selection. Selected library-carrying U937 cells were stored in liquid nitrogen, and cells were thawed and expanded for at least 5 d before differentiation for screens.
Generation of individual sgRNA-expressing U937 and RAW 264.7 cell lines. For generating individual sgRNA phenotypes we lentivirally infected U937 cells stably expressing SFFV-Cas9-BFP or RAW 264.7 cells stably expressing EF1Alpha-Cas9-BFP with constructs expressing a given sgRNA along with puromycin resistance. At 3 d after infection we selected with 1 μ g ml -1 puromycin for U937s and 10 μ g ml -1 puromycin for RAW 264.7 cells for 5 d. In cases where single-cell clonal knockout lines were derived, after puromycin selection, single cells were sorted into 96-well plates and expanded for 2-3 weeks.
Gene editing measurements by Sanger sequencing. Cells were harvested and total genomic DNA was isolated using QuickExtract DNA Extraction Solution (VWR, QE09050). PCR was prepared using 5× GoTaq Green reaction buffer and GoTaq DNA polymerase (Promega, M3005), 10 mM dNTPs and primers designed about 250-350 bp upstream and 450-600 bp downstream of the predicted cut site. PCR reactions were run on a C1000 Touch Thermo Cycler (Bio-Rad). PCR products were then purified over an Econospin DNA column (Epoch, 1910-250) using buffers PB and PE (Qiagen, 19066 and 19065) . Sanger sequencing was performed and applied biosystems sequence trace files (.ab1 files) were obtained from Quintara Biosciences. Editing efficiency of knockout cell lines was analyzed using Synthego's online ICE Analysis Tool.
Phagocytosis substrate preparation. Details for all phagocytosis substrates, IONP labeling reactions and pHrodo labeling reactions are in Supplementary Table 3 . Midbeads, SmallBeads, Bigbeads and Posbeads (Spherotech) were stored at 4 °C and pelleted, and then resuspended in PBS before use. Zymosan (Sigma) was suspended to 10 mg ml -1 in PBS and then filtered through a 40 μ m cell strainer (BD Biosciences) to remove large poorly resuspended material. Myelin was prepared using perfused total brain homogenate from adult rats as described 57 . Myelin concentration was estimated using wet pellet weight, and myelin was stored in single-thaw aliquots of 20-100 mg ml -1 at − 30 °C. Sheep erythrocytes (RBCs, MP Biomedicals) were opsonized following a published protocol 58 before conjugation of IONPs or pHrodo. Briefly, cells were washed with PBS, incubated with polyclonal rabbit anti-sheep RBC IgG or polyclonal rabbit anti-sheep RBC IgM followed by complement factor 5-depleted serum (C5d serum), and then washed repeatedly before storage at 4 °C in dPBS with calcium and magnesium for up to 4 weeks. For unopsonized, IgM-opsonized, or C5d serum-opsonized RBCs, all wash and incubation steps were performed as for complement-opsonized cells except that IgM and/or C5d serum were omitted as appropriate.
Synaptosomes were prepared using perfused whole brain from adult rats based on density centrifugation as described 59 and stored at − 30 °C in single-thaw aliquots.
Amyloid-β aggregates were generated as described 52 by dissolving human β -amyloid(1-42) (Anaspec) in hexafluoroisopropanol, drying, re-dissolving in DMSO, diluting to 200 mM in PBS, and incubating the peptide for 24 h at 4 °C to promote formation of oligomeric amyloid-β aggregates. Amyloid-β aggregates were labeled with pHrodo by adding pHrodo red succinimidyl ester to 200 μ M and incubating the mixture at room temperature for 30 min while it was protected from light on a rocker, after which unconjugated pHrodo dye was separated using size-exclusion Bio-Gel P-6 spin columns prewashed in screening media (Bio-Rad). Amyloid-β aggregates were stored at 4 °C and used within 24 h of aggregation. Amyloid-β was added at 15 mM for phagocytosis assays.
IONP and pHrodo conjugation to phagocytosis substrates. Phagocytosis substrates were covalently labeled at free amine groups with 30 nm-diameter IONPs with N-succinimidyl ester functionalization (Sigma), with pHrodo red succinimidyl ester (ThermoFisher Scientific) or with pHrodo green STP ester (ThermoFisher Scientific). Except for amyloid-β , substrates were pelleted by centrifugation, resuspended in PBS to a fixed concentration and incubated with a set amount of pHrodo or IONP for 45 min at room temperature with gentle shaking. Centrifugation time, substrate concentration and label concentration varied with each substrate as described in Supplementary Table 3 to optimize particle integrity, prevent particle clumping and maximize sensitivity of downstream assays. Supernatants of the final wash did not have detectable levels of fluorescence from free pHrodo dye, and did not result in pHrodo + puncta when incubated with phagocytic cells. After magnet or pHrodo conjugation, phagocytosis substrates were stored in PBS at 4 °C for < 1 week (IONP conjugation) or < 1 month (pHrodo conjugation). RBCs were washed twice immediately before use to remove any lysed cells and minimize risk of heme inhibition of phagocytosis.
MidBeads, SmallBeads and BigBeads lack inherent free amine reactive groups, and so they were sparsely conjugated with putrescine via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, ThermoFisher Scientific) crosslinking before addition of pHrodo. Beads were washed twice in PBS, pH 5.5 (PBS adjusted with HCl) and resuspended to 5% (w/v) in PBS, pH 5.5. The bead suspension was mixed 1:1 with a 1 M putrescine solution before addition of freshly dissolved EDC crosslinker to 1 mg ml -1 . Beads were incubated for 2 h at room temperature before being washed three times in PBS (neutral pH) and resuspended for pHrodo conjugation. The EDC concentration was titrated to prevent bead crosslinking and to incorporate the minimal amount of amine groups that allowed for efficient detection of pHrodo signal at pH 5.5 after subsequent bead labeling.
Magnetic separation-based CRISPR screens. U937 cells carrying the sgRNA library were differentiated with 50 nM PMA for 3 d, trypsinized, and replated at 100 million cells per 15 cm dish as described above. After 2 d of recovery in growth medium lacking PMA, cells were washed eight times with dPBS with calcium and magnesium (dPBS+ , Gibco). Cell medium was exchanged with 15 ml of serum-free U937 growth medium (U937 growth medium lacking FCS) and returned to the incubator for 5 min. Then, 5 ml of prewarmed serum-free U937 growth medium was added containing phagocytosis substrate at the concentrations described in Supplementary Table 3 . Cells were returned to the incubator for a fixed amount of time depending on the prey, as described in Supplementary Table 3 .
After phagocytosis, dishes were rinsed ten times with dPBS+ to remove uningested particles. For screens involving RBCs, dishes were exchanged into ACK lysis buffer and swirled for 10 sec to promote RBC lysis before dPBS+ washes. Cells were then exchanged into 15 ml of Medium A and 100 μ l of trypsin stock solution (30,000 units per ml stock, Sigma) was added to each plate. Cells were returned to the incubator for 10 min to facilitate cell removal from the culture dish and substrate removal from the cell surface. After trypsinization, 3 ml of Medium A containing 10 mM MgCl 2 was added to each dish to minimize cell lysis and bead aggregation. 40 μ l of DNase I stock solution (0.4% DNase, Worthington) was added to each plate to prevent carryover of genomic DNA from lysed cells.
Cells were dislodged from the dish with repeated pipetting and passed through a 40 μ m cell strainer (BD Biosciences) to remove aggregated cells. Cells were subsequently agitated periodically to minimize cell settling and potential aggregation. To maximize cell recovery, 12 ml of separation buffer (12 ml of Medium A with 2 mM MgCl 2 and 0.1% milk peptone (Sigma)) with 0.001% DNase I was added to each dish and the remaining cells were recovered with a cell scraper. Scraped cells were pipetted repeatedly, passed through a 40 μ m cell strainer (BD Biosciences) and combined with pipetted cells.
Next, cells were passed over 4-6 LS magnetic columns (Miltenyi) equilibrated with separation buffer and mounted in the magnetic holder. Only 2 ml of cell suspension was applied to each column at a time, and it was allowed to drain before immediate addition of an additional 2 ml of cell suspension. Column flowthrough was collected and reserved as the unbound fraction. After all of the cell suspension had been loaded, columns were washed three times with 2 ml of separation buffer and flowthrough was combined with the unbound fraction. After three washes, columns were removed from the magnetic apparatus and 3 ml of separation buffer was gently flushed through the demagnetized column with a syringe plunger. The column eluate was reserved as the bound fraction. EDTA was added to achieve a final concentration of 2 mM to each fraction and cells were pelleted by centrifugation (7 min at 300g, room temperature). Cells were resuspended in 90% FCS and 10% DMSO with 2 mM EDTA and frozen in cell freezing containers at − 80 °C for subsequent genomic DNA extraction.
For pilot experiments and to determine the phagocytosis duration required to capture the majority of U937 cells on the magnet, the above experiments were scaled down to 6-well plates. For cytochalasin D experiments, cytochalasin D was added to 10 μ M at 5 min before addition of phagocytosis substrate. After recovery of the bound and unbound fractions, cells were resuspended in dPBS+ containing 1.33 μ M calcein AM (Invitrogen) to visualize live cells.
Screen analysis.
At the end of each screen genomic DNA was extracted for all screen populations separately according to the protocol included with QIAGEN Blood Maxi Kit. Using known universal sequences present in the lentivirally incorporated DNA, sgRNA sequences were amplified and prepared for sequencing by two sequential PCR reactions as described 39 . Products were sequenced using an Illumina Nextseq to monitor library composition (30-40 million reads per library). Trimmed sequences were aligned to libraries using Bowtie, with zero mismatches tolerated and all alignments from multimapped reads included.
Guide composition and comparisons across bound and unbound fractions were analyzed using casTLE 39 version 1.0. Briefly, for each pair of bound and flowthrough samples, guides with < 25 counts in both conditions were removed from the analysis. If a guide had < 25 counts in a single condition, this value was changed to be equal to 25 counts. Enrichment of individual sgRNAs was then calculated as a median-normalized log ratio of the fraction of counts, as described 60 . For each gene, a maximum likelihood estimator was used to identify the most likely effect size and associated log-likelihood ratio (confidence score) by comparing the distribution of gene-targeting guides to a background of nontargeting and safe-targeting guides. P values were then estimated by permuting gene-targeting guides, and hits were called using FDR thresholds (Supplementary  Table 1 ) calculated via the Benjamini-Hochberg procedure. For small-scale retest and FACS screens, a similar analysis was used except genes were called as hits when their effect score at 95% credible interval did not include zero 61, 62 (Supplementary  Table 5 ). Additionally, for small-scale magnetic screens, a count threshold of 100 was used to adjust for higher sequencing coverage. Permutations were not used to calculate P values for small-scale retest screens as a large fraction of guides in these screens are expected to have effects on phagocytosis. Two more stringent analyses were also included: (1) requiring genes to pass the 95% credible interval in both individual replicates and (2) analysis of the small-scale retest screening using MAGeCK (ref.
63; Supplementary Table 5 ). MAGeCK (version 0.5.6) was run using the 'mageck test' command supplied with the '--norm-method control' option and otherwise with default options. pHrodo phagocytosis assay. U937 cells were differentiated as described above for magnetic separation. After 3 d of PMA exposure, cells were lifted, centrifuged and re-plated in 96-well tissue culture plates at a density of 50,000 cells per well in 100 μ l U937 growth medium. After an additional 2 d of recovery, nonadherent cells were eliminated by being washed twice with dPBS. Then, dPBS was removed and replaced with prewarmed serum-free U937 growth medium (U937 growth medium lacking 10% FBS) containing the appropriate pHrodo-labeled phagocytosis substrate(s) at the concentration denoted in Supplementary Table 3 .
Some experiments included cytochalasin D (10 μ M) in the serum-free U937 growth medium for select wells. For fatty-acid rescue experiments (Fig. 5) , fatty acids (Cayman Chemical) were added first to U937 growth medium used when cells were plated in 96-well plates, and second to serum-free U937 growth medium containing phagocytosis substrates (C18s, stearic acid and oleic acid at 3 μ g ml -1 each or lignoceric acid and nervonic acid at 3 μ g ml -1 each, all from ethanol stocks). All cell plating in 96-well plates, washing and addition of phagocytosis substrates were performed using a multichannel pipette.
After addition of phagocytosis substrates, cells were returned to the incubator and imaged at 30-60 min intervals using an Incucyte (Essen). The first time point (reported as t = 0) was typically acquired within 5-20 min of cells returning to the incubator. Reported values are averaged over four fields per well, with at least four wells used per data point. Images were acquired at × 20 objective at 400 ms (green) or 800 ms (red) exposures per field. After the last imaging time point, calcein-AM (Invitrogen) was added to a final concentration of 1.33 μ M. Cells were incubated with calcein-AM for 15 min before a final image acquisition to determine total live cell area per field. No visual decrement in cell survival or health was noticeable after 24 h of imaging in serum-free medium.
To calculate a phagocytic index for each well, the total pHrodo-positive area was determined for each time point and normalized to the total calcein-positive live cell area measured immediately after the 5 h time point. Total area was calculated using automated analysis scripts that performed a fixed-value adaptive background subtraction and selected signal-positive regions that passed intensity thresholds. Different analysis scripts were generated for each phagocytosis substrate to accurately report signal from ingested material. Cellular localization and accurate selection of pHrodo or calcein signal were confirmed visually.
For phagocytosis assays with RAW 264.7 cells, cells were plated at 25,000 cells per well of a 96-well plate. One day later, cells were washed twice with dPBS and exchanged into serum-free RAW cell growth medium. For cells transduced with constitutively active Rac1, Rac1 expression was induced by addition of 5 ng ml -1 doxycycline at the time of transfer to 96-well plates and doxycycline was removed upon transfer to serum-free medium for phagocytosis assays. RAW 264.7 cell phagocytosis was imaged and analyzed as for U937 cells.
For additional methods see Supplementary Note.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Code availability. casTLE version 1.0 is available at https://bitbucket.org/ dmorgens/castle.
Data availability
The RNA-seq FASTQ files are available at GEO under accession GSE107566.
